Quick Asked: Ultivue Contact Us?

Are you searching for Ultivue Contact Us? By using our below available official links ( which are always up to date), you can find contact information without any difficulty. It may list Phone number, Mobile phone, Email Address & Customer service information.
Last update: 25 Apr, 2024 124 Views

Listing Results Ultivue Contact Us? Question Answers

Ultivue Crunchbase Company Profile & Funding

Phone Number (781)883-1531 Ultivue is a biotechnology company that specializes in tissue imaging, diagnostics, and multiplexing. Ultivue produces reagents that enable researchers to obtain microscopic images at an unprecedented resolution that helps to understand of ...

Ultivue Employee Reviews Glassdoor

This assessment is as of Nov 2020. - Ultivue's technology shows lot of promise (good customer demand, and U-VUE shows good product market fit) - Fast paced if you enjoy that - Competent scientific staff. Cons. - Company no longer innovates - ...

Ultivue Overview, News & Competitors ZoomInfo.com

(617) 945-2662 Ultivue’s headquarters are in 763D Concord Ave, Cambridge, Massachusetts, 02138, United States What is Ultivue’s phone number? Ultivue’s phone number is (617) 945-2662 What is Ultivue’s official website? Ultivue’s official website is www.ultivue.com What is Ultivue’s Revenue? Ultivue’s revenue is $6 Million What is Ultivue’s SIC code?

Digital Pathology & AI Congress: USA

This spring the Digital Pathology & AI Congress is being held virtually. The agenda explores the latest developments in applying artificial intelligence and machine learning to primary diagnosis and clinical research and examines the strategies needed to deploy the technology.. The platform we have chosen is designed to facilitate collaboration between the multiple stakeholders who ...

Ultivue, Inc. MassBio

617-845-2662 Ultivue, Inc. Cambridge, MA 617-845-2662 Website Overview Ultivue is an early stage life sciences tools company based in Cambridge MA. Ultivue seeks a better way to see the world – the ultimate view.

Services Inquiry ultivue

Sharon is currently a board director at 908 Devices, Emulate, Isoplexis, Ultivue, and Vizgen. She was previously CFO of Sands Capital Management. Over her 15 years with Sands Capital, assets under management grew from $1.5 billion to $50 billion.

Ultivue : Quotes, Address, Contact

(617) 945-2662 Address. 763D Concord Avenue. Cambridge. Massachusetts, 02138-1044. United States. Phone: 1 (617) 9452662. Visit Website Request Information/Quote Download PDF Copy. Recent Tweets. It’s TIGIT TiME!

Terms and Conditions Ultivue

These Terms and Conditions for Sales of Products constitute a binding legal agreement between Ultivue, Inc. (“Ultivue”) and the customer or authored distributor (“Purchaser” refers to either the customer and/or authorized distributor) unless alternative terms are set forth in a signed written agreement between Ultivue and the Purchaser.

Ultivue Company Profile: Valuation & Investors PitchBook

+1 (617) 000-0000 Contact Information Website www.ultivue.com Ownership Status Privately Held (backing) Financing Status Venture Capital-Backed Primary Industry Other Healthcare Technology Systems Other Industries Biotechnology Drug Discovery Primary Office 763D Concord Avenue Cambridge, MA 02138-1044 United States +1 (617) 000-0000 Ultivue Timeline

UVUE Biomarker Menu ultivue

alpha-sma arg1 b-catenin bcl2 bcl-xl bcma bim cd11b cd11c cd138 cd14 cd15 cd155 cd163 cd19 cd20 cd206 cd22 cd226 cd27 cd28 cd299 cd3 cd31 cd335 cd38 cd39 cd4 cd40 cd45ro cd56 cd68 cd68/cd163 cd70 cd8 cd80 cd86 cd96 ck ck/sox10 ck/sox10/ck8/18 ck18 ck8 ck8/18 clec10a clec9a ctla4 dc-lamp desmin dgka dgkz fap foxp3 gitr granzyme b hla dr hla1 id01 inos ki-67 ...

Ultivue Raises $22 Million in Series C Funding ultivue

Contact Us. Ultivue Raises $22 Million in Series C Funding. CAMBRIDGE, Mass, June 27, 2019 – Ultivue, the innovation leader in tissue biomarker identification and quantification assays for translational and pathology research labs, today announced the close of a $22 Million Series C funding led by new investor Northpond Ventures and fueled by

Ultivue Inc Company Profile and News Bloomberg Markets

Ultivue Inc. Ultivue, Inc. was founded in 2015. The company's line of business includes providing commercial physical and biological research and development. SECTOR. Health Care.

Multiplex Immunofluorescence & Tissue Biomarkers ...

The Ultivue assay is designed to deliver fast results. Our proprietary InSituPlex technology reduces the tissue staining protocol to around 5.5 hours, enabling same-day sample to analysis. While the UltiMapper kits offer a fixed set of markers to observe a number of different phenotypes within tissue, the Ultivue Services Lab is able to provide

Ultivue Company Profile Office Locations, Competitors

Ultivue has 106 employees across 2 locations and $57.3 m in total funding,. See insights on Ultivue including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.

Ultivue – MetaGene Pty Ltd

Ultivue. Using proprietary technology Ultivue offers clinical scientists and researchers with the ability to understand the complex tumor micro-environment. With the application of DNA-barcoded antibodies multiplex biomarker assays for tissue phenotyping and digital pathology are now so much easier. Ultivue’s proprietary InSituPlex

Ultivue LinkedIn

About us. Ultivue develops innovative reagent-based solutions that maximize the biological information available from cells and tissue samples. The company's technology is ...

Ultivue ten24 Digital Solutions

Ultivue has a rather complex order and post-order process. But with Slatwall in place, it doesn’t matter whether a customer orders by phone with a credit card, faxes a purchase order, or visits the Ultivue website and orders directly.

UltiMapper® I/O Immuno8™ (Ultivue)

Translational immuno-oncology research often requires the visualization of multiple cell phenotypes in FFPE tissue sections. Ultivue’s UltiMapper® I/O and U-VUE® kits allow for pre-optimized staining of up to 12 targets in a single tissue section using exchange technology with sequential imaging of targets across two or three imaging rounds. Final high-plex images ...

Home Ultivue

A new standard for multiplex immunofluorescence (mIF) solutions has arrived. Utilize, discover, and design biomarker panels to profile the immune landscape in your tissues with unprecedented clarity. With ready-to-use panels, innovative software tools and image analysis services, Ultivue is an ideal partner to outsource your assay development

Ultivue Webinar Features HALO Image Analysis: EndtoEnd

In this webinar, the Ultivue technology and UltiMapper™ I/O kits will be introduced including a fully optimized, automated and optimized staining protocol on the Leica BOND RX platform. Avoiding any linear unmixing after image acquisition, the UltiMapper I/O whole slide images are directly analyzed using the then processed on Indica Labs HALO software, to derive cell ...

Did the information help you? If so, please share!
If you think the information on this page has been helpful to you, would you be willing to share it? Your sharing is the driving force for our continuous work.